|
Myasthenia
Citations 41-50 of 67 total displayed.
|
Past content
(since Jan 2001):
|
- BRIEF COMMUNICATIONS
Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis
- M. Takamori, M. Motomura, N. Kawaguchi, Y. Nemoto, T. Hattori, H. Yoshikawa, and K. Otsuka
Neurology 2004; 62: 1894-1896.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Joint pain and hyperalgesia due to pyridostigmine bromide in a patient with myasthenia gravis
- Anna Rostedt and Erik Stålberg
Neurology 2004; 62: 835-836.
[Full text]
[PDF]
- VIEWS & REVIEWS
Treatment of autoimmune myasthenia gravis
- David P. Richman and Mark A. Agius
Neurology 2003; 61: 1652-1661.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Myasthenia gravis: Consequences for pregnancy, delivery, and the newborn
- Jana Midelfart Hoff, Anne Kjersti Daltveit, and Nils Erik Gilhus
Neurology 2003; 61: 1362-1366.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Mycophenolate mofetil for myasthenia gravis: An analysis of efficacy, safety, and tolerability
- M.N. Meriggioli, E. Ciafaloni, K.A. Al-Hayk, J. Rowin, B. Tucker-Lipscomb, J.M. Massey, and D.B. Sanders
Neurology 2003; 61: 1438-1440.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Rapsyn mutations in hereditary myasthenia: Distinct early- and late-onset phenotypes
- G. Burke, J. Cossins, S. Maxwell, G. Owens, A. Vincent, S. Robb, M. Nicolle, D. Hilton–Jones, J. Newsom–Davis, J. Palace, and D. Beeson
Neurology 2003; 61: 826-828.
[Abstract]
[Full text]
[PDF]
- ARTICLES
D4F104S1 deletion in facioscapulohumeral muscular dystrophy: Phenotype, size, and detection
- R. J.L.F. Lemmers, M. Osborn, T. Haaf, M. Rogers, R. R. Frants, G. W. Padberg, D. N. Cooper, S. M. van der Maarel, and M. Upadhyaya
Neurology 2003; 61: 178-183.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Clinical aspects of MuSK antibody positive seronegative MG
- D. B. Sanders, K. El-Salem, J. M. Massey, J. McConville, and A. Vincent
Neurology 2003; 60: 1978-1980.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients
- J. S. Müller, G. Mildner, W. Müller–Felber, U. Schara, K. Krampfl, B. Petersen, S. Petrova, R. Stucka, W. Mortier, J. Bufler, G. Kurlemann, A. Huebner, L. Merlini, H. Lochmüller, and A. Abicht
Neurology 2003; 60: 1805-1810.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Treatment of slow-channel congenital myasthenic syndrome with fluoxetine
- C. Michel Harper, Takayasu Fukodome, and Andrew G. Engel
Neurology 2003; 60: 1710-1713.
[Abstract]
[Full text]
[PDF]
|
|
